pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Gonal-F
drug
save

follitropin alfa

Marketedupdated 3mo ago
by EMD Serono Inc
Approved
community read0 votes

🐶 often sniffed alongside

top 6
  • tagApproval24 co-mentions · 12 sources
  • drugFOLLISTIM AQ24 co-mentions · 12 sources
  • companyOrganon USA LLC12 co-mentions · 12 sources
  • drugicosapent ethyl12 co-mentions · 12 sources
  • drugfollitropin beta12 co-mentions · 12 sources
  • drugfollitropin12 co-mentions · 12 sources

all catalysts(0)

nothing on the calendar yet

Trials studying follitropin alfa

  • phase3A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)recruitingn=266
  • phase1An Ethno-bridging Study of Pergoveris in Healthy Premenopausal Participants of Japanese or Caucasian Origincompletedn=24
  • phase1A Study to Assess the Bioequivalence of Follitropin Alfa Solution in Pen and Follitropin Alfa Powder in Vial in Healthy Downregulated Male Participantscompletedn=55
  • phase1Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteersactive not recruitingn=48
  • phase3A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in Chinacompletedn=301
  • phase4Phase IV Study to Evaluate the Efficacy and Safety of Fang Le Shu Compared to Guo Na Fen for Controlled Ovarian Stimulation in Infertile Women Undergoing in Vitro Fertilization-embryo Transfer (IVF-ET).recruitingn=248
  • phase3A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulationcompletedn=302
  • phase3Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian Womencompletedn=220
more trials →

News(0)

no news has mentioned this drug yet

brand
Gonal-F
generic
follitropin alfa
indication
Anovulation
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?